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Retroviral-like proteinases (RVPs) are aspartic proteinases
belonging to the A2 family of peptidase enzymes [1] and are found
in retroviruses and retrotransposon elements. In the retroviridae,
these proteinases are crucial for proteolytic processing of the retro-
viral polyprotein and are targets for proteinase inhibitors [2]. They
are characteristically dimeric in order to deploy two active site
aspartic acids, one from each monomer, to coordinate the catalytic
water molecule in this class of proteinase [3]. In contrast to the
well-studied A1 family aspartic proteinases typiﬁed by enzymes
such as pepsin, retroviral-type proteinases are poorly characterised
outside the retroviridae although important functions for such pro-
teins have been proposed in maintenance of epithelial layers in
mammalian skin [4]. A family of proteins containing an RVP do-
main that is conserved throughout the eukaryota has been identi-
ﬁed [5] and the best-studied member of this family is the DNA
damage inducible protein Ddi1 (also known as VSM1) of the yeast
Saccharomyces cerevisiae.
Ddi1 is involved in a number of cellular processes including
protein targeting to the proteasome, control of cell cycle andchemical Societies. Published by Esuppression of protein secretion from the cell and these are med-
iated by different regions of the protein. Fig. 1 shows a diagram-
matic representation of Ddi1. The N-terminal region (residues
1–190) contains a ubiquitin-like sequence (UBL, residues 1–
75); the second domain has a sequence [5] and three-dimensional
fold [6] with characteristics of an RVP (residues 191–324); this
is followed by the C-terminal segment (residues 325–428) con-
taining a t-SNARE binding region (residues 344–395) and a
ubiquitin associated (UBA) domain at its C-terminus (residues
395–428). Ddi1 is part of the ubiquitin-proteasome system [7]
and the UBA and UBL domains mediate these roles. UBA appears
to be important in the interactions of Ddi1 with some of its part-
ner proteins such as Rad23 (a protein involved in nucleotide exci-
sion and repair) [8]. Deletion of the UBA region also renders cells
defective in S-phase checkpoint control [9]. The UBA domains of
both Ddi1 and Rad23 interact directly with ubiquitin [10,11]
and Ddi1 UBA domain interactions with ubiquitinated proteins
may deliver them to the proteasome through interactions of the
Ddi1 UBL domain with the proteasome [12]. The UBL domain
associations with the proteasome play a role in the control of cell
cycle [10,12–14].
The homodimerisation of Ddi1 is independent of the presence of
the UBA domain [8] and relies on the RVP domain [15]. The dimeri-
sation of the Ddi1-RVP alone can be seen clearly in the crystallsevier B.V. All rights reserved.
Fig. 1. Structure of the Ddi1 protein and constructs used. The ubiquitin-like (UBL),
retroviral proteinase-like (RVP) Sso1 binding (SB) and ubiquitin associated (UBA)
domains are shown. Numbers below indicate approximate residue numbers of the
features shown. The full-length protein is shown along with schematic represen-
tations of truncated constructs used in this study.
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aspartate residue D220 does not affect dimerisation but abolishes
rescue of the checkpointmutant pds1-128 cells so its catalytic activ-
ity may be required for checkpoint regulation [15].
The role of Ddi1 in protein secretion may be mediated via
SNARE proteins making it a negative regulator of secretion. Ddi1
appears to interact with the Snc2 v-SNARE of the yeast late secre-
tory pathway and Ddi1 knockout mutants lead to an increase in
protein secretion to the medium [16]. The C-terminal domain ami-
no acids 344–395 are important for interactions with Sso1 t-SNARE
and this region is phosphorylated at T346 and T348 with the latter
being necessary for Sso1 binding [15]. The binding of Ddi1 to Sso1
competes with the binding of a further t-SNARE, Sec9, so Ddi1 is
proposed as an inhibitor of SNARE assembly in yeast [17]. While
the role of the putative active site of the RVP domain has been
established for checkpoint control (see above), its potential
involvement in the protein export phenotype is yet to be estab-
lished. In this work we show that both the N-terminal region of
Ddi1 and the putative catalytic activity of the RVP region contrib-
ute to the suppression of protein secretion, with both features
being required for full suppression.2. Materials and methods
2.1. Yeast strains
The S. cerevisiae strains used in this study were BY4742 (MATa
his3D leu2D0 lys2D0 ura3D0) and the DDI1 knockout derivative
Y16141 (MATa his3D1 leu2D0 lys2D0 ura3D0 YER143w::kanMX4)
and were supplied by EUROSCARF, Frankfurt, Germany.
S. cerevisiae strains were cultured using YEPD medium (10 g/l
yeast extract, 20 g/l glucose, 20 g/l bacto-peptone, 0.1 g/l uracil
and 0.1 g/l adenine) or selective minimal medium (1.6 g/l yeast
nitrogen base that does not contain ammonium chloride or amino
acids, 20 g/l glucose, 5 g/l ammonium chloride, 20 lg/ml histidine,
20 lg/ml lysine and 20 lg/ml uracil).Fig. 2. Ddi1 complementation of secretion phenotype. Protein secretion into the
medium was measured per mg cell dry weight for strain BY4742 yeast (n = 24), for
the DDI1 knockout strain Y16141 (n = 24), and for strain Y16141 transformed with
pVTL260 vector encoding full-length Ddi11–428 (Ddi1, n = 24), plasmid pVTL260
alone (vector, n = 15), and pVTL260 encoding the D220A Ddi1 active site mutation
(Ddi1 D220A, n = 27), the RVP alone (n = 20), the RVP alone with the D220A
mutation (RVP D220A, n = 20), the C-terminally truncated Ddi1 (DC, n = 6), the C-
terminally truncated Ddi1 with the D220A mutation (DC D220A, n = 6), the N-
terminally truncated Ddi1 (DN, n = 6), the N-terminally truncated Ddi1 with the
D220A mutation (DN D220A, n = 6). Error bars indicate standard errors of the
means.2.2. Ddi1 constructs
Full length DDI1 was ampliﬁed from S. cerevisiae strain BY4742
by PCR using EasyA DNA polymerase (Stratagene, La Jolla,
California) with forward primer Ddif (CCATGGGATGGATTTAA-
CAATTTCAAACGAAC) and reverse primer Ddir (GGATCCTCATTG-
GAAAAGGAGGGATGC) which contained NcoI or BamHI sites
respectively at their 50 ends. The conditions used were 95 C for5 min followed by 30 cycles of: 95 C for 1 min, 60 C for 1 min;
72 C for 1 min; prior to a ﬁnal elongation step of 72 C for 5 min.
Ddi1 truncate constructs (Ddi1180–325, Ddi1180–428 and
Ddi11–325) were ampliﬁed as described above using the following
forward and reverse primer pairs: Ddi180f (CCATGGCAACAAGC-
TATC GATGAACAG) + Ddi325r (GGATCCTTATGGGATTTCCGCTTC-
ACT); Ddi180f + Ddir; Ddif + Ddi325r, respectively. Point mutation
of the Ddi1 active site aspartate to alanine in each of the constructs
was performed by PCR using the QuickChange Site-Directed muta-
genesis kit (Stratagene, La Jolla, California) employing forward
and reverse primers (GTAAAGGCATTTGTAGCTACAGGGGCTCAAAC;
TGTTTGAGCCCCTGTAGCTACAAATGCCTTTAC).
The resultant PCR products were ligated into the pGEM-T vector
(Promega, Southampton, UK) and sequenced. The DNA inserts were
excised with NcoI and BamHI and cloned into yeast expression
vector pVTL260 [18]. The pVTL260 constructs were transformed
into S. cerevisiae Y16141 (a DDI1 knockout derivative of strain
BY4742) by the lithium acetate transformation method [19].
2.3. Secretion assay
Previously described secretion assays for DDI1 knockout strains
have used radioactive pulse chase [16]. We wished to avoid the use
of radiolabel and also to normalise our secretion data based on cell
numbers since Ddi1 is known to affect cell growth rate [16]. In our
assay, one colony from a selective minimal plate, grown overnight
at 30 C was inoculated into 1.5 ml selective minimal medium in a
24 well plate and grown for 48 h at 30 C with shaking in a Micro-
therm plate shaker incubator (Camlab, Cambridge, UK) until an
attenuance at 600 nm of 2 was reached. After this time, 1 ml of
culture was removed into a pre-weighed tube and the supernatant
separated from whole cells by centrifugation at 13 000 rpm for
5 min. The supernatant was removed and the protein content
Fig. 3. Production of Ddi1 and truncations detected by Western blot. Samples
shown are the DDI1 knockout strain Y16141 transformed with pVTL260 vector
alone, the wild-type strain BY4742, and for strain Y16141 producing full-length
Ddi11–428 (Ddi1), the D220A Ddi1 active site mutation (Ddi1 D220A), the RVP alone,
the RVP alone with the D220A mutation (RVP D220A), the C-terminally truncated
Ddi1 (DC), the C-terminally truncated Ddi1 with the D220A mutation (DC D220A),
the N-terminally truncated Ddi1 (DN), the N-terminally truncated Ddi1 with the
D220A mutation (DN D220A).
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shire, UK) with BSA as a standard. The cell pellet was dried at
100 C and weighed so that the protein concentrations determined
could be normalized by expressing the protein concentration as
milligrams of protein secreted per milligram of dry weight. Assays
were repeated multiple times (as shown in Fig. 2 legend).
2.4. Western blotting
Total S. cerevisiae protein samples were prepared as described
by [20]. Pellets obtained from 10 ml of S. cerevisiae grown in min-
imal media liquid culture were resuspended in 750 ll of sterile
H2O and 750 ll of 0.6 M NaOH. The samples were incubated for
10 min at room temperature then centrifuged at 14 000 rpm for
10 min. The supernatant was discarded and the pellet resuspended
in SDS sample buffer (0.6 M Tris–HCl pH 6.8, 5% glycerol, 2% SDS,
4% b-mercaptoethanol and 0.0025% Bromophenol blue). Proteins
were transferred from a SDS–PAGE gel to a nitrocellulose mem-
brane by electroblotting at 145 mA for 45 min using a Hoeder
TE77 semi-dry blotter (GE Healthcare, Buckinghamshire, UK).
Ddi1 protein was detected using a polyclonal rabbit antiserum
raised against Ddi1 [10], kindly provided by Dr. Steve Reed (The
Scripps Research Institute, La Jolla, California, U.S.A.).3. Results
Using our simple secretion assay described above, we conﬁrmed
previous observations [16] that DDI1 gene knockouts showed sig-
niﬁcantly higher levels of protein in the growth medium than the
wild-type parental strain (Fig. 2, BY4742 and Y16141). Transforma-
tion of the knockout yeast with the DDI1 gene in our pVTL260 plas-
mid construct restored secretion to wild-type low levels whilst the
plasmid alone had no effect (Fig. 2, Ddi1 and vector). We wished to
investigate the effects of the putative aspartic proteinase activity
on the secretion phenotype so we tested the ability of the Ddi1-
D220Amutant to affect protein export. The presence of this mutant
partially reduced protein secretion but not to wild-type levels,
indicating that proteolytic activity may play some role in produc-
ing the phenotype but is not entirely responsible (Fig. 2, Ddi
D220A). To conﬁrm that regions beyond the RVP domain have an
inﬂuence on secretion levels, a construct comprising the RVP alone
was used (Ddi1180–325). This also produced a partial reduction in
secretion, again indicating some role for the putative catalytic
activity of the RVP (Fig. 2, RVP). The equivalent RVP construct with
a D220A mutation of the proposed active site aspartate residue
gave high secretion levels, equivalent to those of the knockout
strain (Fig. 2, RVP D220A) further demonstrating the need for an
intact catalytic apparatus.
To identify the region(s) that may also play a role in reducing
secretion we employed a series of deletion mutants. Deletion of
the C-terminal 103 amino acids in Ddi11–325 (removing the Sso1
t-SNARE binding domain and the UBA region) produced a secre-
tion level indistinguishable from wild-type (Fig. 2, DC), indicating
that these C-terminal residues are not involved. Consistent with
the full-length Ddi1 construct, mutation of the active site D220
in the C-terminal deletion mutant produced a secretion proﬁle
that was intermediate between wild-type and knockout
(Fig. 2, DC D220A). Deletion of the N-terminal 179 residues in
Ddi1180–428, produced the partial rescue phenotype seen before
but this was lost on mutation of D220 (Fig. 2, DN and DN
D220A). This conﬁrms that the proteolytic apparatus is impor-
tant in suppressing secretion but also indicates a role for the
N-terminus in this effect.
To establish that the effects described above were not due to
differential levels of expression of the different protein forms,Western blot analysis was performed (Fig. 3). The strains encoding
Ddi1 (with or without mutated active site) produce a comparable
level of the protein to the wild-type BY4742 strain. N- and
C-terminal deletions produced slightly weaker bands (Fig. 3).
Introduction of the D220A mutation does not alter the levels of
proteins produced for any of these constructs. Phenotypic effects
seen are, therefore, the result of the mutations. No bands were seen
on the Western blot for the constructs encoding RVP domains
alone (not shown). However, the antiserum also failed to detect
any bands when we analysed an extract from an Escherichia coli
clone that had been conﬁrmed to express the same RVP region
by N-terminal sequencing of the product (results not shown). Thus,
it appears that the antiserum does not recognise epitopes from this
region. Since both N- and C-terminal deletions are recognised, we
can conclude that the polyclonal antiserum contains antibodies
that can bind to both. The bands seen for full-length Ddi1-produc-
ing strains on the Western blot are approximately twice as intense
as for the N- and C-terminal deletions. This may reﬂect the ability
of full-length Ddi1 to bind antibody at both sites and imply that the
actual levels of accumulation of full-length and truncated Ddi1 are
equivalent. Despite the failure to detect the RVP domain proteins,
we can deduce that this region is produced from the partial pheno-
type of the RVP protein.
Since our results suggest a role for the N-terminal region that
contains the UBL sequence, we analysed sequences of Ddi1 homo-
logs from the databases to assess the conservation of this region.
The Ddi1 UBL domain is a rather divergent example of the ubiq-
uitin-like fold, but does generate a signiﬁcant match to a HMM
representation of the Ubiquitin-like superfamily [21] between
aa1-93 (P = 0.000927), and to the Pfam [22] ubiquitin ‘clan’
(CL0072) between hit aa17-72 (PF11543 UN_NPL4, P = 0.027).
The Superfamily [21] HMM (model 0050055) demonstrating the
best match (P = 0.000927) to the Ddi1 UBL domain was retrieved
and searched against the set of 70 orthologous sequences (Sup-
plementary Table 1) using HMMER (version 3.0; [23]). Signiﬁcant
matches (P < 0.001) were found at the N-terminal ends of 62 se-
quences including Ddi1 itself. Of the remaining 8 sequences, 5
lacked detectable similarity altogether: Schizosaccharomyces pom-
be, Leishmania major, Leishmania infantum, Leishmania mexicana
and Entamoeba histolytica, and a multiple sequence alignment
(not shown) supports the total absence of UBL domains in these
proteins. The other 3 sequences failing to generate signiﬁcant hits
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nalis) do possess N-terminal sequences that are to some extent
alignable with the other orthologs. It is possible that these 3
sequences represent the most divergent UBL domains in the data-
set, or that they lack UBL domains altogether. An HMM was con-
structed from the 62 aligned N-terminal UBL sequences identiﬁed
above within the dataset using HMMER, and used to search the
sequences of the 3 proteins of unknown status (C. elegans,
L. braziliensis, G. intestinalis). The G. intestinalis sequence did
indeed generate a signiﬁcant (P = 5.2e-05) N-terminal hit to this
HMM, supporting the proposition that this sequence also contains
a UBL domain, but the other 2 proteins did not. The C. elegans,
and L. braziliensis proteins were then submitted to PHYRE [24]
to examine structural homology in the absence of sequence level
evidence for UBL domains, but yielded no conﬁdent structural
assignments. The same 2 sequences were also submitted to the
Jpred server [25], which suggests that the secondary structures
are indeed somewhat different from the characteristic structure
seen for the Ddi1 UBL domain. Thus, the UBL sequence shows
widespread but not universal conservation amongst the Ddi1
family of proteins and is lacking in 7 of the 70 sequences
analysed here.
4. Discussion
Using a series of deletion mutants, Gabriely et al. [15] have
elegantly demonstrated that a region from the C-terminal portion
of Ddi1 (residues 344–395) that does not include the UBA region,
is involved in binding to the Sso1 t-SNARE protein; that nuclear
enrichment of Ddi1 requires the presence of the UBA and UBL do-
mains but does not require the putative active site D220 residue;
and that suppression of the pds1-128 growth defect requires the
UBA, UBL and the presence of D220. Here we show a further role
for D220, along with the N-terminal region of Ddi1 in suppression
of secretion. We ﬁnd no evidence for the involvement of the
C-terminal region of Ddi1 in this secretion phenotype. This
is, perhaps, unexpected since Ddi1 binding via the residues
344–295 in the C-terminal region to Sso1 is competitive with
the binding of Sec9. Normal formation of a Sec9–Sso complex is
expected to lead to exocytosis and Ddi1 is, thus, predicted to be
an inhibitor of this process [17]. Deletion of the C-terminal region
that includes both the UBA and the Sso1 binding region might be
expected to relieve this inhibition and produce increased
secretion. Our results indicate that the C-terminal region is not
important for the secretion phenotype and indicate instead that
crucial sequences for the suppression of protein export lie in the
N-terminal 179 residues and the supposed active site of the RVP
domain. These two factors appear to have independent inﬂuences
on secretion since either alone provides a partial repression but
they seem to act in concert to provide the complete wild-type
secretion-repressed phenotype. A new role for the N-terminal
region in protein secretion is, thus, revealed. The lack of absolute
sequence conservation of the N-terminal UBL region implies that
this region may not be crucially involved. However, the lack of
other conserved sequences between the UBL and RVP domains
leaves the nature of the sequences involved in suppression of
secretion to be elucidated. However, these results provide further
evidence in support of the proposal that the Ddi1 protein is an
active aspartic proteinase that requires a functional catalytic
apparatus to execute its full range of cellular functions. Further
investigations of this catalytic activity are now required to under-
stand the role of this protein that is highly conserved across the
full spectrum of the eukaryotes.Acknowledgement
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Appendix A. Supplementary data
Supplementary data (Ddi1 orthologs analysed for UBL domains)
associated with this article can be found, in the online version, at
doi:10.1016/j.febslet.2010.11.026.
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